Page last updated: 2024-10-27

furazolidone and Glycogenosis

furazolidone has been researched along with Glycogenosis in 2 studies

Furazolidone: A nitrofuran derivative with antiprotozoal and antibacterial activity. Furazolidone acts by gradual inhibition of monoamine oxidase. (From Martindale, The Extra Pharmacopoeia, 30th ed, p514)
furazolidone : A member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czarnecki, CM2
Jegers, A1
Jankus, EF2
Salam, A1
Caldwell, R1

Other Studies

2 other studies available for furazolidone and Glycogenosis

ArticleYear
Characterization of glycogen in selected tissues of turkey poults with spontaneous round heart disease and furazolidone-induced cardiomyopathy.
    Acta anatomica, 1978, Volume: 102, Issue:1

    Topics: Animals; Cardiomyopathies; Furazolidone; Glucose; Glycogen; Glycogen Storage Disease; Glycogen Stora

1978
Activity of alpha-1, 4-glucosidase in furazolidone-induced glycogenosis.
    Poultry science, 1978, Volume: 57, Issue:1

    Topics: alpha-Glucosidases; Animals; Furazolidone; Glucosidases; Glycogen Storage Disease; Liver; Male; Poul

1978